About ANI Pharmaceuticals
ANI Pharmaceuticals is a company based in Baudette (United States) founded in 1996. ANI Pharmaceuticals has completed 5 acquisitions, including Alimera Sciences, H2-Pharma and Inderalxl.
- Headquarter Baudette, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Alimera Sciences
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ANI Pharmaceuticals
ANI Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol ANIP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of ANI Pharmaceuticals
Unlock access to complete
Unlock access to complete
Leadership Team
84 people
Product Management Team
15 people
Sales and Marketing
11 people
Finance and Accounting
7 people
Operations Team
7 people
Software Development Team
6 people
Human Resources and Administration
6 people
Field Team
3 people
Unlock access to complete
Funding Insights of ANI Pharmaceuticals
Investments & Acquisitions by ANI Pharmaceuticals
ANI Pharmaceuticals has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Alimera Sciences, H2-Pharma and Inderalxl.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic prescription medications are developed, manufactured, and distributed.
|
2016 | ||||
|
Distributor of generic pharmaceutical drugs
|
2013 | ||||
|
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
|
2003 |
Financial Statements - ANI Pharmaceuticals
Ani Pharmaceuticals Comparisons
Competitors of ANI Pharmaceuticals
Frequently Asked Questions about ANI Pharmaceuticals
ANI Pharmaceuticals was founded in 1996.
ANI Pharmaceuticals is headquartered in Baudette, United States. It is registered at Baudette, Minnesota, United States.
Arthur Przybyl is the current CEO of ANI Pharmaceuticals.
ANI Pharmaceuticals was founded in 1996 and is headquartered in Baudette, United States. Operations focus on the pharmaceutical sector, where branded and generic prescription drugs are developed, manufactured, and marketed. A range of bio-pharmaceutical products is offered to address patient needs across various therapeutic areas. The company maintains a diversified portfolio to support healthcare providers and patients in the U.S. market.
Yes, ANI Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol ANIP.
ANI Pharmaceuticals has made 5 acquisitions, including Alimera Sciences, H2-Pharma, and Inderalxl.
The ticker symbol of ANI Pharmaceuticals is ANIP on NASDAQ.